Structures by: Abourahma H.

Total: 28

1,4,7,10,13-pentaoxacyclopentadecane ethanedithioamide clathrate

C10H20O5,C2H4N2S2

Simonov, Yurii A.Fonari, Marina S.Zaworotko, Michael J.Abourahma, HebaLipkowski, JanuszGanin, Edward V.Yavolovskii, Arkadii A.

Organic & Biomolecular Chemistry (2003) 1, 16 2922

a=8.2660(5)Å   b=8.6440(6)Å   c=12.5320(10)Å

α=80.053(3)°   β=81.737(3)°   γ=75.392(3)°

Cis-syn-cis (A) isomer (2,3,11,12-dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane bis(ethanedithioamide) clathrate

C20H36O6,2(C2H4N2S2)

Simonov, Yurii A.Fonari, Marina S.Zaworotko, Michael J.Abourahma, HebaLipkowski, JanuszGanin, Edward V.Yavolovskii, Arkadii A.

Organic & Biomolecular Chemistry (2003) 1, 16 2922

a=23.72000(10)Å   b=7.6550(2)Å   c=18.3640(3)Å

α=90.0000°   β=106.9810(6)°   γ=90.0000°

1,4,7,10,13,16-hexaoxacyclooctadecane N,N'- (thiocarbamoyl)hydrazine clathrate

C12H24O6,C2H6N4S2

Simonov, Yurii A.Fonari, Marina S.Zaworotko, Michael J.Abourahma, HebaLipkowski, JanuszGanin, Edward V.Yavolovskii, Arkadii A.

Organic & Biomolecular Chemistry (2003) 1, 16 2922

a=14.196(3)Å   b=7.187(2)Å   c=19.552(3)Å

α=90.00°   β=92.18(2)°   γ=90.00°

Cis-anti-cis (B) isomer (2,3,11,12-dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane bis(ethanedithioamide) clathrate

C20H36O6,2(C2H4N2S2)

Simonov, Yurii A.Fonari, Marina S.Zaworotko, Michael J.Abourahma, HebaLipkowski, JanuszGanin, Edward V.Yavolovskii, Arkadii A.

Organic & Biomolecular Chemistry (2003) 1, 16 2922

a=12.654(3)Å   b=7.5700(15)Å   c=17.129(3)Å

α=90.00°   β=106.14(3)°   γ=90.00°

1,4,7,10,13-pentaoxacyclopentadecane bis(N,N'- (thiocarbamoyl)hydrazine) clathrate

C10H20O5,2(C2H6N4S2)

Simonov, Yurii A.Fonari, Marina S.Zaworotko, Michael J.Abourahma, HebaLipkowski, JanuszGanin, Edward V.Yavolovskii, Arkadii A.

Organic & Biomolecular Chemistry (2003) 1, 16 2922

a=13.632(3)Å   b=9.475(2)Å   c=19.185(4)Å

α=90.00°   β=90.00°   γ=90.00°

1,4,7,10-tetraoxacyclododecane N,N'-(thiocarbamoyl)hydrazine clathrate

C8H16O4,C2H6N4S2

Simonov, Yurii A.Fonari, Marina S.Zaworotko, Michael J.Abourahma, HebaLipkowski, JanuszGanin, Edward V.Yavolovskii, Arkadii A.

Organic & Biomolecular Chemistry (2003) 1, 16 2922

a=18.475(4)Å   b=18.445(4)Å   c=9.443(2)Å

α=90.00°   β=90.00(3)°   γ=90.00°

C34H22N2O8Zn2

C34H22N2O8Zn2

Moulton, BrianAbourahma, HebaBradner, Michael W.Lu, JianjiangMcManus, Gregory J.Zaworotko, Michael J.

Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343

a=30.2394(11)Å   b=30.2394(11)Å   c=18.2791(13)Å

α=90.00°   β=90.00°   γ=120.00°

C53.25H31Cu4N3O17

C53.25H31Cu4N3O17

Moulton, BrianAbourahma, HebaBradner, Michael W.Lu, JianjiangMcManus, Gregory J.Zaworotko, Michael J.

Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343

a=10.6661(12)Å   b=30.303(4)Å   c=16.3650(19)Å

α=90.00°   β=95.877(2)°   γ=90.00°

C17H11CoNO6.48

C17H11CoNO6.48

Moulton, BrianAbourahma, HebaBradner, Michael W.Lu, JianjiangMcManus, Gregory J.Zaworotko, Michael J.

Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343

a=30.3087(15)Å   b=30.3087(15)Å   c=18.3364(13)Å

α=90.00°   β=90.00°   γ=120.00°

C34H22Cu2N2O8

C34H22Cu2N2O8

Moulton, BrianAbourahma, HebaBradner, Michael W.Lu, JianjiangMcManus, Gregory J.Zaworotko, Michael J.

Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343

a=30.337(2)Å   b=30.337(2)Å   c=18.380(2)Å

α=90.00°   β=90.00°   γ=120.00°

C200H72Cu24O206.4S4

C200H72Cu24O206.4S4

Abourahma, HebaColeman, Anthony W.Moulton, BrianRather, BethShahgaldian, PatrickZaworotko, Michael J.

Chemical Communications (2001) 22 2380

a=31.111(4)Å   b=31.111(4)Å   c=35.999(6)Å

α=90.00°   β=90.00°   γ=90.00°

Theophylline-melamine

C12H20N10O3S

Abourahma, HebaUrban, Jennifer M.Morozowich, NicoleChan, Benny

CrystEngComm (2012) 14, 19 6163

a=15.4964(11)Å   b=8.8674(6)Å   c=13.2985(9)Å

α=90.00°   β=109.4230(10)°   γ=90.00°

Anthranilic acid Pyrazinamide

C7H7NO2,C5H5N3O

Abourahma, HebaCocuzza, Devon S.Melendez, JesusUrban, Jennifer M.

CrystEngComm (2011) 13, 21 6442

a=7.2482(10)Å   b=7.5827(10)Å   c=12.2794(16)Å

α=77.826(2)°   β=84.096(2)°   γ=63.018(2)°

C34H22N2O8Zn2

C34H22N2O8Zn2

Moulton, BrianAbourahma, HebaBradner, Michael W.Lu, JianjiangMcManus, Gregory J.Zaworotko, Michael J.

Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343

a=30.2394(11)Å   b=30.2394(11)Å   c=18.2791(13)Å

α=90.00°   β=90.00°   γ=120.00°

C53.25H31Cu4N3O17

C53.25H31Cu4N3O17

Moulton, BrianAbourahma, HebaBradner, Michael W.Lu, JianjiangMcManus, Gregory J.Zaworotko, Michael J.

Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343

a=10.6661(12)Å   b=30.303(4)Å   c=16.3650(19)Å

α=90.00°   β=95.877(2)°   γ=90.00°

C17H11CoNO6.48

C17H11CoNO6.48

Moulton, BrianAbourahma, HebaBradner, Michael W.Lu, JianjiangMcManus, Gregory J.Zaworotko, Michael J.

Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343

a=30.3087(15)Å   b=30.3087(15)Å   c=18.3364(13)Å

α=90.00°   β=90.00°   γ=120.00°

C34H22Cu2N2O8

C34H22Cu2N2O8

Moulton, BrianAbourahma, HebaBradner, Michael W.Lu, JianjiangMcManus, Gregory J.Zaworotko, Michael J.

Chemical Communications (Cambridge, United Kingdom) (2003) 12 1342-1343

a=30.337(2)Å   b=30.337(2)Å   c=18.380(2)Å

α=90.00°   β=90.00°   γ=120.00°

2(Pyrazinamide).(4-nitrobenzoic acid)

C7H5NO4,2(C5H5N3O)

Abourahma, HebaShah, Dhaval D.Melendez, JesusJohnson, Elizabeth J.Holman, K. Travis

Crystal Growth & Design (2015) 15, 7 3101

a=3.6371(11)Å   b=36.541(11)Å   c=6.564(2)Å

α=90.00°   β=94.998(3)°   γ=90.00°

C25H24Cu2N4O9

C25H24Cu2N4O9

Abourahma, HebaBodwell, Graham J.Lu, JianjiangMoulton, BrianPottie, Ian R.Walsh, Rosa BaileyZaworotko, Michael J.

Crystal Growth & Design (2003) 3, 4 513

a=8.2043(13)Å   b=14.970(2)Å   c=10.6012(16)Å

α=90.00°   β=90.191(3)°   γ=90.00°

C18H10CuNO5

C18H10CuNO5

Abourahma, HebaBodwell, Graham J.Lu, JianjiangMoulton, BrianPottie, Ian R.Walsh, Rosa BaileyZaworotko, Michael J.

Crystal Growth & Design (2003) 3, 4 513

a=18.7912(8)Å   b=18.7912(8)Å   c=16.8886(10)Å

α=90.00°   β=90.00°   γ=90.00°

C22H16Cu2O10S4

C22H16Cu2O10S4

Abourahma, HebaBodwell, Graham J.Lu, JianjiangMoulton, BrianPottie, Ian R.Walsh, Rosa BaileyZaworotko, Michael J.

Crystal Growth & Design (2003) 3, 4 513

a=15.637(4)Å   b=15.430(4)Å   c=13.332(3)Å

α=90.00°   β=116.692(4)°   γ=90.00°

C26H26Cu2N4O9

C26H26Cu2N4O9

Abourahma, HebaBodwell, Graham J.Lu, JianjiangMoulton, BrianPottie, Ian R.Walsh, Rosa BaileyZaworotko, Michael J.

Crystal Growth & Design (2003) 3, 4 513

a=8.4851(15)Å   b=14.639(2)Å   c=11.1455(19)Å

α=90.00°   β=93.392(3)°   γ=90.00°

C30H28Cu2N2O12

C30H28Cu2N2O12

Abourahma, HebaBodwell, Graham J.Lu, JianjiangMoulton, BrianPottie, Ian R.Walsh, Rosa BaileyZaworotko, Michael J.

Crystal Growth & Design (2003) 3, 4 513

a=18.8743(16)Å   b=18.8743(16)Å   c=17.356(3)Å

α=90.00°   β=90.00°   γ=90.00°

C33H26Cu2N3O10.5

C33H26Cu2N3O10.5

Abourahma, HebaBodwell, Graham J.Lu, JianjiangMoulton, BrianPottie, Ian R.Walsh, Rosa BaileyZaworotko, Michael J.

Crystal Growth & Design (2003) 3, 4 513

a=10.2527(12)Å   b=18.973(2)Å   c=16.977(2)Å

α=90.00°   β=100.460(2)°   γ=90.00°

C24H38Cu2N2O20S4

C24H38Cu2N2O20S4

Heba AbourahmaBrian MoultonVictor KravtsovMichael J. Zaworotko

Journal of the American Chemical Society (2002) 124, 9990-9991

a=14.0608(12)Å   b=13.8902(12)Å   c=19.0465(16)Å

α=90.00°   β=98.487(2)°   γ=90.00°

C34H26Cl2Cu2N2O8

C34H26Cl2Cu2N2O8

Abourahma, HebaBodwell, Graham J.Lu, JianjiangMoulton, BrianPottie, Ian R.Walsh, Rosa BaileyZaworotko, Michael J.

Crystal Growth & Design (2003) 3, 4 513

a=19.5148(14)Å   b=12.7678(9)Å   c=14.3466(10)Å

α=90.00°   β=114.1330(10)°   γ=90.00°

C41H40CuN6O9S0.08

C41H40CuN6O9S0.08

Heba AbourahmaBrian MoultonVictor KravtsovMichael J. Zaworotko

Journal of the American Chemical Society (2002) 124, 9990-9991

a=35.023(4)Å   b=35.023(4)Å   c=9.9711(13)Å

α=90.00°   β=90.00°   γ=120.00°